Clinical Trials Browser

Phase 1/2 × Completed × romiplostim × Clear all

NCT00299182 2021-09-21

Study of AMG 531 to Evaluate the Safety & Efficacy in Patients With Non-Hodgkin's Lymphoma

Phase 1/2 Completed

50 enrolled 11 charts

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell

NCT00515203 2014-07-25

Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects

Phase 1/2 Completed

22 enrolled 13 charts 1 FDA

Purpura, Thrombocytopenic, Purpura, Thrombocytopenic, Idiopathic

NCT00147225 2014-05-08

AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin

Phase 1/2 Completed

55 enrolled 11 charts

Classical hematology

Thrombocytopenia

NCT00283439 2011-06-20

A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma

Phase 1/2 Completed

39 enrolled 13 charts

Classical hematologyLymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Thrombocytopenia